Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 21537039

Phase II trial of bevacizumab in recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2011 Jun 1
First author
Aghajanian C

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Aghajanian C
      type
      Author
    2. name
      Sill MW
      type
      Author
    3. name
      Darcy KM
      type
      Author
    4. name
      Greer B
      type
      Author
    5. name
      McMeekin DS
      type
      Author
    6. name
      Rose PG
      type
      Author
    7. name
      Rotmensch J
      type
      Author
    8. name
      Barnes MN
      type
      Author
    9. name
      Hanjani P
      type
      Author
    10. name
      Leslie KK
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Aghajanian C
      type
      Author
    2. name
      Sill MW
      type
      Author
    3. name
      Darcy KM
      type
      Author
    4. name
      Greer B
      type
      Author
    5. name
      McMeekin DS
      type
      Author
    6. name
      Rose PG
      type
      Author
    7. name
      Rotmensch J
      type
      Author
    8. name
      Barnes MN
      type
      Author
    9. name
      Hanjani P
      type
      Author
    10. name
      Leslie KK
      type
      Author
    bibliography ids
    1. nci-bib-0b977ad57f21d285eb293fac
    book metadata
    content sha256
    595778a3481e3d748bc51e54c7cb68142b628ed9b37553e2f6b96594a91110dd
    document type
    citation
    dois
    1. 10.1200/JCO.2010.32.6397
    electronic publication date
    display
    2011 May 2
    precision
    day
    year
    2011
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:21537039
    immutable id
    pubmed:21537039@595778a3481e3d748bc51e54c7cb68142b628ed9b37553e2f6b96594a91110dd
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    16
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    2259-65
    volume
    29
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      21537039
      provenance
      batch id
      a366a1bc8ed89d8d7ca5
      provider
      NCBI PubMed ESummary
      record sha256
      f90a4c027d7b0ff44ee8a2e1323c84d5b6c84abd555eacf0d39d76419f174b24
      response sha256
      c4fde29a469958f2f95ac1ef059ab1994169370e37d8293c0823efce81dabbb8
      retrieved at
      2026-09-09T23:46:40.540025+00:00
      publication date
      display
      2011 Jun 1
      precision
      day
      year
      2011
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Research Support, N.I.H., Extramural
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/21537039/
      title
      Phase II trial of bevacizumab in recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study.

      Preserved source evidence · Not medical advice